项目 | 分类 | 例数 | 5年生存率(%) | χ2值 | P值 |
年龄 | <50 | 72 | 66.7% | 0.108 | 0.742 |
≥50 | 84 | 65.5% |
|
| |
肿瘤部位 | 中线型 | 75 | 78.7% | 10.284 | 0.001 |
侧位型 | 81 | 54.3% |
|
| |
合并自身免疫性疾病 | 有 | 87 | 49.4% | 24.169 | <0.001 |
无 | 69 | 87.0% |
|
| |
BMI指数 | <28 | 93 | 72.0% | 4.346 | 0.037 |
≥28 | 63 | 57.1% |
|
| |
肿瘤类型 | 鳞癌 | 122 | 70.5% | 5.698 | 0.017 |
非鳞癌 | 34 | 50.0% |
|
| |
肿瘤大小 | ≤2 cm | 75 | 68.0% | 0.219 | 0.640 |
>2 cm | 81 | 64.2% |
|
| |
浸润深度 | ≤1 mm | 85 | 83.5% | 27.692 | <0.001 |
>1 mm | 71 | 45.1% |
|
| |
脉管浸润 | 有 | 52 | 59.6% | 1.656 | 0.198 |
无 | 104 | 69.2% |
|
| |
淋巴结转移 | 有 | 81 | 37.0% | 66.387 | <0.001 |
无 | 75 | 97.3% |
|
| |
分化程度 | 高分化 | 82 | 69.5% | 0.591 | 0.744 |
中分化 | 48 | 62.5% |
|
| |
低分化 | 26 | 61.5% |
|
| |
肿瘤分期 | I期 | 36 | 72.2% | 8.73 | 0.033 |
II期 | 70 | 74.3% |
|
| |
III期 | 34 | 50.0% |
|
| |
IV期 | 16 | 50.0% |
|
| |
治疗方式 | 手术 | 61 | 65.6% | 8.519 | 0.036 |
手术 + 放化疗 | 68 | 75.0% |
|
| |
放化疗 | 23 | 47.8% |
|
| |
未治疗 | 4 | 25.0% |
|
|